CHWY vs PETS

For growth investors, Chewy, Inc.

(CHWY) is the stronger pick with 6. 4% revenue growth year-over-year, versus -17. 2% for PetMed Express, Inc. (PETS). Chewy, Inc. (CHWY) offers the better valuation at 27. 0x trailing P/E (28. 1x forward), making it the more compelling value choice. Analysts rate Chewy, Inc. (CHWY) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Chewy, Inc.

(CHWY) delivered a total return of -65. 6%, compared to -82. 6% for PetMed Express, Inc. (PETS). Over 10 years, the gap is even starker: CHWY returned -29. 7% versus PETS's -45. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Chewy, Inc.

(CHWY) is the lower-risk stock at 0. 70β versus PetMed Express, Inc. 's 1. 25β — meaning PETS is approximately 77% more volatile than CHWY relative to the S&P 500. On balance sheet safety, PetMed Express, Inc. (PETS) carries a lower debt/equity ratio of 1% versus 192% for Chewy, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Chewy, Inc.

(CHWY) is pulling ahead at 6. 4% versus -17. 2% for PetMed Express, Inc. (PETS). On earnings-per-share growth, the picture is similar: Chewy, Inc. grew EPS 893. 4% year-over-year, compared to 18. 9% for PetMed Express, Inc.. Over a 3-year CAGR, CHWY leads at 9. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Chewy, Inc.

(CHWY) is the more profitable company, earning 3. 3% net margin versus -2. 8% for PetMed Express, Inc. — meaning it keeps 3. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CHWY leads at 0. 9% versus -0. 7% for PETS. At the gross margin level — before operating expenses — PETS leads at 30. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, PETS (0.

4% yield) pays a dividend. CHWY does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Chewy, Inc.

(CHWY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70)). Both have compounded well over 10 years (CHWY: -29. 7%, PETS: -45. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CHWY (Consumer Cyclical) and PETS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.